Recent studies have revealed that several genetic polymorphisms may play important roles in the pathogenesis of ovarian cancer[14,15], and women who carried the gene mutation (BRCA1 mutation) had an increased risk (by up to 50%) of developing ovarian cancer in a lifetime[16]. Here, BRCA1 is linked to ovarian carcinoma.